Collegium Pharmaceutical Financials

Values in thousands	2026-06-30	2026-03-31	2025-12-31	2025-09-30
Revenue	$199,878	$193,520	$205,449	$209,361
Gross Profit	110,292	117,246	128,378	129,171
EBITDA	70,752	90,538	303,566	121,709
EBIT	5,987	34,602	133,830	65,203
Net Income	-15,051	14,496	16,963	31,507
Net Change In Cash	199,878	193,520	205,449	209,361
Free Cash Flow	70,827	56,843	122,359	78,250
Cash	129,467	268,648	251,102	169,946
Basic Shares	32,460	40,065	39,701	39,439

Values in thousands	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	$780,567	$631,449	$566,767	$463,933
Gross Profit	463,257	377,344	326,169	209,488
EBITDA	401,005	341,702	308,328	173,305
EBIT	174,931	172,542	159,072	34,366
Net Income	62,870	69,190	48,155	-25,002
Net Change In Cash	780,567	631,449	566,767	463,933
Cost of Revenue				-12,738
Free Cash Flow	327,583	203,328	274,288	122,608
Cash	251,102	70,565	238,947	173,688
Basic Shares	39,701	40,424	41,788	33,829